---
title: "603882.SH (603882.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603882.SH/news.md"
symbol: "603882.SH"
name: "603882.SH"
parent: "https://longbridge.com/en/quote/603882.SH.md"
datetime: "2026-05-21T05:56:54.482Z"
locales:
  - [en](https://longbridge.com/en/quote/603882.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603882.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603882.SH/news.md)
---

# 603882.SH (603882.SH) — Related News

### [Healthcare Industry Daily (05.03): New Developments in the Medical Field](https://longbridge.com/en/news/285002802.md)
*2026-05-03T19:12:18.000Z*
> The Medical Health Industry Daily (05.03) reported several important developments: Lin Chuixu, Deputy General Manager of

### [Kingmed Diagnostics released its first-quarter performance, turning a loss into a profit of 42.7905 million yuan](https://longbridge.com/en/news/284058117.md)
*2026-04-24T22:01:06.000Z*
> Kingmed Diagnostics released its first quarter report for 2026, with operating revenue of 1.351 billion yuan, a year-on-

### [Overview of A-share Stock Buybacks: 15 Companies Disclose Buyback Progress](https://longbridge.com/en/news/282397127.md)
*2026-04-11T00:28:20.000Z*
> On April 11th, 15 companies announced their stock repurchase progress, among which 1 company proposed a repurchase, 7 co

### [](https://longbridge.com/en/news/282323306.md)
*2026-04-10T09:47:05.000Z*
> Kingmed Diagnostics: Plans to repurchase company shares for RMB 150 million to 200 million; the repurchase price per sha

### [Traditional pharmaceutical companies layout in the nuclear medicine track, third-party medical testing capitalizes on big data, Nansha leads in the field of gene therapy](https://longbridge.com/en/news/280232863.md)
*2026-03-23T23:04:14.000Z*
> Guangzhou is actively laying out in the field of biomedicine, especially in nuclear medicine and gene therapy. Kingmed D

### [Kingmed Diagnostics launches early screening service for breast cancer with three-gene methylation](https://longbridge.com/en/news/277923799.md)
*2026-03-05T11:07:00.000Z*
> According to Kingmed Diagnostics, in response to the pain points of insufficient accuracy and low compliance of traditio

### [Kingmed Diagnostics: Completed industrial and commercial change registration and reissued business license](https://longbridge.com/en/news/277018970.md)
*2026-02-26T09:59:09.000Z*
> Kingmed Diagnostics announced that on January 21, 2026, the company will hold its first extraordinary shareholders' meet

### [New Stock News | Zhuozheng Medical's margin subscription oversubscribed by over 2,700 times, with participation from He Xiaopeng, Kingmed Diagnostics, and Tencent ecosystem companies as cornerstone investors](https://longbridge.com/en/news/274901724.md)
*2026-02-05T02:28:04.000Z*
> On February 3rd, domestic health service consumption company Zhuozheng Medical's IPO ended with a strong market response